Brief: Orbimed Advisors Llc Reports Stake Of 13.4% In Turnstone Biologics As Of July 20
24/07/2023 21:45
July 24 (Reuters) - Turnstone Biologics Corp TSBX.O :
* ORBIMED ADVISORS LLC REPORTS STAKE OF 13.4% IN TURNSTONE
BIOLOGICS AS OF JULY 20 - SEC FILING
Further company coverage: TSBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Turnstone Biologics
See all newsBrief: Turnstone Biologics to Be Acquired by XOMA for $0.34/Share Plus Contingent Value Right
U.S. STOCKS ON THE MOVE-Walmart, crypto, banks
Turnstone rises as company cuts job, changes executives
Brief: Turnstone Biologics Sees One-Time Severance-Related Charge Associated With Workforce Reduction To Be About $2.3 Million
Brief: Turnstone Biologics Announces Strategic Restructuring To Prioritize Portfolio And Extend Financial Runway